On Wednesday, Haleon (NYSE: HLN), the consumer healthcare company, said it will invest $54 million in its global research and development center in Richmond, U.S., aiming to boost its pipeline for new product innovations.
The company said the investment is in addition to its 300 million pounds ($372.5 million) annual spending in R&D.
The Richmond facility is one of the three R&D centers of excellence for Haleon, along with Weybridge, UK, and Suzhou, China.
($1 = 0.8053 pounds)
